W. Rathmell
Last active: 11/27/2019

  1. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E (2017) Cancer Res 77(19): 5313-5326
    › Primary publication · 28807937 (PubMed) · PMC5626626 (PubMed Central)
  2. Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. Chang EH, Chong WK, Kasoji SK, Fielding JR, Altun E, Mullin LB, Kim JI, Fine JP, Dayton PA, Rathmell WK (2017) BMC Nephrol 18(1): 266
    › Primary publication · 28793871 (PubMed) · PMC5551034 (PubMed Central)
  3. Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling. Siska PJ, Johnpulle RAN, Zhou A, Bordeaux J, Kim JY, Dabbas B, Dakappagari N, Rathmell JC, Rathmell WK, Morgans AK, Balko JM, Johnson DB (2017) Oncoimmunology 6(4): e1305535
    › Primary publication · 28507813 (PubMed) · PMC5414873 (PubMed Central)
  4. Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma. Murakami A, Wang L, Kalhorn S, Schraml P, Rathmell WK, Tan AC, Nemenoff R, Stenmark K, Jiang BH, Reyland ME, Heasley L, Hu CJ (2017) Oncogenesis 6(1): e287
    › Primary publication · 28092369 (PubMed) · PMC5294252 (PubMed Central)
  5. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD (2017) Cancer Cell 31(2): 181-193
    › Primary publication · 28162975 (PubMed) · PMC5643159 (PubMed Central)
  6. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP (2017) Cell 171(3): 540-556.e25
    › Primary publication · 28988769 (PubMed) · PMC5687509 (PubMed Central)
  7. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network (2017) Cell 169(7): 1327-1341.e23
    › Primary publication · 28622513 (PubMed) · PMC5680778 (PubMed Central)
  8. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cancer Genome Atlas Research Network. Electronic address: elizabeth.demicco@sinaihealthsystem.ca, Cancer Genome Atlas Research Network (2017) Cell 171(4): 950-965.e28
    › Primary publication · 29100075 (PubMed) · PMC5693358 (PubMed Central)
  9. Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma. Beckermann KE, Jolly PC, Kim JY, Bordeaux J, Puzanov I, Rathmell WK, Johnson DB (2017) J Immunother Cancer : 1
    › Primary publication · 28105368 (PubMed) · PMC5240268 (PubMed Central)
  10. Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study. Yin Q, Hung SC, Wang L, Lin W, Fielding JR, Rathmell WK, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D (2017) Sci Rep : 43356
    › Primary publication · 28256615 (PubMed) · PMC5335708 (PubMed Central)